Prime Medicine, Inc.
Company Stats
- Market Cap
- $554.1M
- as of Sep 30, 2026
- Shares Outstanding
- 181.4M
- Free Float
- 52.6%
Income Statement
- Revenue
- $4.6M
- Operating Income
- -$208.3M
- Net Income
- -$201.1M
- EBITDA
- -$201.0M
Cash Flow
- Free Cash Flow
- -$167.1M
- FCF Yield
- -30.2%
- Owner FCF Yield
- -35.4%
Balance Sheet
- Cash & Equivalents
- $63.0M
Returns & Capital
- SBC, 3Y Avg
- $23.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.6M | -$167.1M | -3607.4% |
| FY2024 | $3.0M | -$130.2M | -4363.4% |
| FY2023 | $0 | -$174.1M | — |
| FY2022 | $0 | -$147.9M | — |
| FY2021 | $0 | -$38.2M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back